1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Mitigating the impact of study-start delays in clinical trials for rare disorders : insights and lessons from a PKAN trial
- Contribution to journal › Article
- 2022
-
Mark
A “patient-industry complex”? Investigating the financial dependency of UK patient organisations on drug company funding
- Contribution to journal › Article
- 2019
-
Mark
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
- Contribution to journal › Article
- 2013
-
Mark
Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
- Contribution to journal › Article